Herpes simplex virus ocular infections

Drugs of Today

Volumn 34, Issue 3, 1998, Pages 241-249

  Lee, Stephen Y ^a,b  

^a WILLS EYE HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 (3 HYDROXY 2 PHOSPHONOMETHOXYPROPYL)ADENINE; ACICLOVIR; ADEFOVIR; CYCLOSPORIN; ORYZACYSTATIN; TRIFLURIDINE; VALACICLOVIR; VIDARABINE;

ANTIVIRAL ACTIVITY; BLEPHARITIS; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG POTENCY; HERPES SIMPLEX KERATITIS; HUMAN; INFECTION RISK; KERATOPLASTY; PLACENTAL TRANSFER; RECURRENT INFECTION; REVIEW; VIRAL CONJUNCTIVITIS;

EID: 0031982054     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1998.34.3.485179     Document Type: Review

References (32)

1. Pavan-Langston, D. Viral diseases of the cornea and external eye. In: Principles and Practice of Ophthalmology. Jakobiec, F., Albert, D. (Eds.). W.B. Saunders Co.: Philadelphia 1994, 117-61.
2. Liesegang, T., Melton, J. III, Daly, P. et al. Epidemiology of ocular herpes simplex: Incidence in Rochester, Minnesota, 1950 through 1982. Arch Ophthalmol 1989, 107: 1155.
3. Whitley, R., Nahmias, A., Visintine, A. et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980, 4: 489.
4. Azazi, M., Gunilla, M., Forsgren, M. Late ophthalmologic manifestations of neonatal herpes simplex virus infection. Am J Ophthalmol 1990, 109: 1.
5. Pavan-Langston, D., Rong, B., Dunkel, E. Extraneural herpetic latency: Animal and human corneal studies. Acta Ophthalmol 1989, 192 (Suppl.): 135.
6. Spear, P. Glycoproteins specified by herpes simplex viruses. In: The Herpesviruses, Vol. 3. Roizman, B. (Ed.). Plenum Press: New York 1985, 315.
7. Kaufman, H., Varnell, E., Centifanto, Y. et al. Effect of herpes simplex virus genome on the response of infection to steroids. Am J Ophthalmol 1985, 100: 114.
8. Spruance, S., Stewart, J., Rowe, N. et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990, 161: 185.
9. Tullo, A.B. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. In: Documenta Ophthalmologica Proceedings: Herpetic Eye Diseases. Maudgal, P.C., Missoten, L. (Eds.). Dordrecht, Netherlands 1984, 57.
10. Wilhelmus, K.R., Gee, L., Hauck, W.W. et al. Herpetic eye disease study: A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994, 101: 1883.
11. McVoy, G.K. Acyclovir. In: American Society of Health System Pharmacists Drug Information 1990, 353.
12. Schaffer, H.J. Acyclovir chemistry and spectrum of activity. Am J Med 1982, 73: 4.
13. Elion, G.B. Mechanism of action and selectivity of acyclovir. Am J Med 1982, 73: 7.
14. Hung, S.O., Patterson, A., Rees, P.J. Oral acyclovir in the management of dendritic herpetic corneal ulceration. Br J Ophthalmol 1984, 68: 398.
15. Pavan-Langston, D. Herpetic keratitis: Inhibition of epithelial recurrences with long-term oral acyclovir. Proc New Engl Ophthalmol Meet (Oct 21) 1992.
16. Barren, B., Gee, L., Hauck, W.W. et al. Herpetic eye disease study: A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994, 101: 1871.
17. The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. To be published.
18. Epstein, R.J., Seedor, J.A., Dreizen, N.G. et al. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Ophthalmology 1987, 94: 935.
19. Kok van Alphen, C.C., Volker-Dieben, J.M. Prevention and treatment of herpes recurrence in the corneal graft with acyclovir. In: Documenta Ophthalmologies Proceedings: Herpetic Eye Diseases. Maudgal, P.C., Missoten, L. (Eds.). Dordrecht, Netherlands 1985, 319.
20. Barney, N., Foster, C.S. A prospective randomized trial of oral acyclovir following penetrating keratoplasty for herpes. Cornea 1994, 13: 232.
21. Beutner, K.R. Valacyclovir: A review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995, 28: 281-90.
22. Tyring, S.K. Efficacy of famciclovir in the treatment of herpes zoster. Semin Dermatol 1996, 15: 27-31.
23. Maudgal, P.C., DeClercq, E.D. (S)-1-(3-Hydroxy-2-phosphonyl-methoxypropyl) cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis. Inv Ophthalmol Vis Sci 1991, 32: 1816.
24. Aoki, H., Akaike, T., Abe, K. et al. Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo. Antimicrob Agents Chemother 1995, 39: 846.
25. Staats, H.F., Oakes, J.E., Lausch, R.N. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J Virol 1991, 65: 6008.
26. Inoue, Y., Oh, J.O., Minasi, P. Protective effect of anti-glycoprotein D antibody on herpetic chorioretinitis in newborn rabbits. Curr Eye Res 1991, 10 (Suppl.): 159.
27. Colin, J., Malet, F., Chastel, C., Richard, M.C. Use of collagen shields in the treatment of herpetic keratitis. Curr Eye Res 1991, 10 (Suppl.): 189.
28. Willey, D.E., Williams, I., Faucett, C., Openshaw, H. Ocular acyclovir delivery by collagen discs: A mouse model to screen antiviral agents. Curr Eye Res 1991, 10 (Suppl.): 167.
29. Naito, T., Nitta, K., Kinouchi, Y., Shiota, H., Mimura, Y. Effects of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbits. Curr Eye Res 1991, 10(Suppl.): 201.
30. Taylor, J.L. Punda-Polic, V., O'Brien, W.J. Combined anti-herpes virus activity of nucleoside analogs and interferon. Curr Eye Res 1991, 10 (Suppl.): 205.
31. Klager, A.J., Bucht, E.R., Osusky, R. et al. Topical immunoglobulins for epithelial herpes simplex keratitis. Ophthalmologica 1993, 207: 78.
32. Nesbum, A.B., Burke, R.L., Ghiasi, H. et al. Vaccine therapy for ocular herpes simplex virus infection: Periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits. J Virol 1994, 68: 5084-92.